Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.
Center for Primary Health Care Research, Lund University, 205 02 Malmö, Sweden.
Sci Rep. 2016 Jun 22;6:28500. doi: 10.1038/srep28500.
Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high.
浆细胞疾病包括意义未明的单克隆丙种球蛋白血症(MGUS)、多发性骨髓瘤(MM)、华氏巨球蛋白血症(WM)和轻链 AL 淀粉样变性,其特征是浆细胞克隆性扩张,产生大量免疫球蛋白衍生的 M 蛋白。我们注意到 MGUS 诊断通常与老年白内障和青光眼的诊断同时发生,并在 1997 年至 2012 年间,通过瑞典患者登记处,对 MGUS、MM、WM 和 AL 淀粉样变性与随后的眼部疾病之间的关联进行了检测。MGUS 后老年白内障的标准化发病比(SIR)显著增加至 1.80,MM 后增加至 1.70,WM 后增加至 1.85,AL 淀粉样变性后增加至 2.31。MGUS 后青光眼的 SIR 为 1.60,WM 后为 1.76,AL 淀粉样变性后为 2.18。所有 SIR 均从 60 岁以下年龄组到 79 岁以上年龄组系统性降低,但在 79 岁以上年龄组,大多数风险仍然显著。M 蛋白和相关的血液粘度增加可能是这些常见眼病的新病因发现。由于 60 岁时 MGUS 的患病率约为 3%,80 岁以上时接近 10%,因此其对眼部疾病负担的贡献预计将非常高。